Mylexa

Mylexa

closed

Spin-out from the Australian National University developing a novel treatment for the management of allergic diseases, including hayfever and asthma.

HQ location
South Australia, Australia
Launch date
https://www.linkedin.com/company/mylexa-pty-ltd/
    • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round

AUD250k

Grant
Total Funding000k
Government of South Australia
Government of South Australia
Australian National University
Australian National University

Related Content

Notes (0)
More about Mylexa
Edit

Mylexa Pty Ltd is an early-stage biopharmaceutical company established in March 2009 by ANU Connect Ventures to develop a new treatment for allergic diseases, including allergic rhinitis. The Company’s proprietary technology was invented by researchers at The Australian National University's John Curtin School of Medical Research and The Canberra Hospital and offers the prospect of controlling mast cell activation, a pivotal process in the onset of a variety of allergic diseases.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads